SPDR S&P Biotech ETF $XBI Shares Newly Bought by Fearless Solutions LLC dba Best Invest

Fearless Solutions LLC dba Best Invest bought a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 3,430 shares of the exchange traded fund’s stock, valued at approximately $541,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Avoro Capital Advisors LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth approximately $256,053,000. Bank of America Corp DE lifted its stake in SPDR S&P Biotech ETF by 13.3% in the first quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock valued at $1,854,388,000 after purchasing an additional 1,700,851 shares during the last quarter. OMERS ADMINISTRATION Corp lifted its stake in SPDR S&P Biotech ETF by 42,425.2% in the fourth quarter. OMERS ADMINISTRATION Corp now owns 1,190,707 shares of the exchange traded fund’s stock valued at $145,147,000 after purchasing an additional 1,187,907 shares during the last quarter. Main Street Research LLC lifted its stake in SPDR S&P Biotech ETF by 57.4% in the first quarter. Main Street Research LLC now owns 567,479 shares of the exchange traded fund’s stock valued at $72,484,000 after purchasing an additional 206,953 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. grew its holdings in SPDR S&P Biotech ETF by 145.7% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 314,224 shares of the exchange traded fund’s stock valued at $49,726,000 after purchasing an additional 186,314 shares during the period.

SPDR S&P Biotech ETF Price Performance

NYSEARCA:XBI opened at $146.80 on Wednesday. The business has a fifty day simple moving average of $158.57 and a two-hundred day simple moving average of $146.52. SPDR S&P Biotech ETF has a 1 year low of $103.43 and a 1 year high of $169.89. The company has a market capitalization of $9.84 billion, a P/E ratio of 11.47 and a beta of 0.83.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.